Roche Pipeline Already Genentech-Loaded
This article was originally published in The Pink Sheet Daily
Executive Summary
Candidates In Phase II And BeyondHow much of Genentech is in Roche's pipeline? Quite a bit. Of the 27 programs in Phase II development or later, one-third have their origins in Genentech's laboratories. Here's a summary of the crucial drugs and on-going clinical trials. (Source: Company websites)